In 2015, London School of Economics hosted a special event to mark the 10th anniversary of Health Economics, Policy and Law (HEPL). Invited members of the HEPL editorial board delivered short presentations, reflecting on issues that they thought posed particular challenges to the development of health care systems over the next decade.

Videos of all of these presentations are now available on the HEPL homepage here.

The short presentations included:

– Scott Greer (University of Michigan) and Tom Rice (UCLA) discuss the US Affordable Care Act and how the upcoming election might affect health care.

– Tamara Hervey (University of Sheffield) discusses the European Union and health care, and introduces her new book European Union Health Law: Themes and Implications.

– Isabelle Durand Zaleski (University of Paris XII), Giovanni Fattore (Bocconi University) and Karsten Vrangbaek (University of Copenhagen) discussing health economics and policy within Europe.

– Julian Le Grand (LSE) and Albert Weale (UCL) discussing the NHS in its current state.

– Peter Smith (Imperial College London) and Mark Stabile (University of Toronto) discussing public health care and welfare system supported by governments across the globe.

– Jan-Kees Helderman (Radboud University Nijmegen) and Martin Knapp (LSE) discussing how health care is having to respond to advances in science and research.

These fine scholars provide us all with a wealth of insight to reflect upon. I, for one, would be impoverished without them.
Alongside the event, a series of commentaries were commissioned from HEPL’s International Advisory Board which featured in a special issue of the journal which is free to access until the end of 2016. These reflected on an article that had appeared in HEPL since its founding. Reflecting the very broad interests across the Board, the breadth of topics covered in the issue included: Beveridge vs Bismarck systems; cost-effectiveness analysis; end-of-life care; equity in health care; EU health law; genetic testing; globalisation and trade in health care services; governance structures; health technology assessment; human resources; lifestyle interventions; patient choice; performance management; public involvement in health policy; public vs private financing; tobacco lobbying; social capital; the social value of life; and US health care reform.

Revised post based on original posted on the LSE blog, available here.